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Community acquired UTI is common, and causes considerable 
morbidity and health expense. The presence of sufficient numbers 
of bacterial organisms and an inflammatory reaction indicates UTI. 
Approximately 90% are due to one of three organisms (E.coli, 
Klebsiella, Proteus). Testing for UTI includes urinary dipstick 
testing, which is rapid but prone to false positives. Alternatively, 
urine samples may be cultured, but this requires laboratory facilities 
and technical staff, and is slow and expensive. Often patients are 
treated on symptoms alone, and this risks over-treatment, i.e. 
some patients erroneously thought to have UTI receiving antibiotics 
inappropriately. GP concerns (inappropriate antibiotics, costs) and 
patient concerns (delayed treatment) make UTI management a 
significant issue. Internationally, emerging multi-resistant organisms 
mandates major public health focus to reduce inappropriate 
prescribing. 
A UTI point-of-care (POC) diagnostic has been identified as the 
highest priority diagnostic for GPs. We have formed a collaborative 
team to adapt and exploit a technology developed by the University 
of the West of England that can be used by GPs, community 
nurses, pharmacists and others to identify and quantify the 
presence of the three species of bacteria that are commonly 
present in urinary tract infections; diagnosis of UTI is being 
confirmed by the presence of an additional biomarker.
This poster introduces some of the factors we are considering to 
ensure the diagnostic rigour, clinical applicability, and user-centric 
design of this product, and the exploitation and adoption routes that 
we are exploring concurrently with the technology development.  
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